Look for:

Our offer for

AMGEN INC.


ISIN:
US0311621009
WKN:
031162100

2022/11/28 17:35:10
Price
286.075 USD
Difference 0.51% (1.45)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)145,785 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)284.80 USD (1)
Ask (Ask size)287.35 USD (280)
Open286.075 USD
High285.00 USD
Low285.00 USD
Close (prev. day)284.625 USD
VWAP285.00 USD
Volume (pcs)2,902
Trading volume750,120.00
Number of trades5
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: AMGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/11/28 17:35:10
Price
286.075 USD
Difference 0.51% (1.45)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)145,785 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)284.80 USD (1)
Ask (Ask size)287.35 USD (280)
Open286.075 USD
High285.00 USD
Low285.00 USD
Close (prev. day)284.625 USD
VWAP285.00 USD
Volume (pcs)2,902
Trading volume750,120.00
Number of trades5
Last size-

Performance and Risk

6M1Y3Y
Perf (%)+11.51%+39.71%+22.23%
Perf (abs.)+29.43+81.00+51.83
Beta0.410.360.64
Volatility22.3622.4926.05
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)284.480 USD (0)
Ø price 30 days | Ø volume 30 days (pcs.)276.109 USD (50)
Ø price 100 days | Ø volume 100 days (pcs.)252.172 USD (4,504)
Ø price 250 days | Ø volume 250 days (pcs.)241.594 USD (6,191)
YTD High | date295.450 USD (2022/11/09)
YTD Low | date219.000 USD (2022/02/21)
52 Weeks High | date295.450 USD (2022/11/09)
52 Weeks Low | date200.800 USD (2021/12/02)

All listings for AMGEN INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/11/2817:35275.60 EUR0.0419
Vienna Stock Exchange2022/11/2817:32275.60 EUR0.026
Tradegate2022/11/2908:03273.20 EUR0.011
Stuttgart2022/11/2908:02273.20 EUR0.001
SIX Swiss Exchange2022/11/1417:36180.00 CHF0.001
SIX Swiss Exchange---0.00-
Nasdaq2022/11/2822:00282.62 USD674.8041,053
Munich2022/11/2908:00274.25 EUR0.001
London Stock Exchange2022/11/2817:35286.075 USD0.755
Hong Kong Stock Exchange2021/02/1102:201,761.00 HKD--
Hanover2022/11/2908:01272.25 EUR0.001
Hamburg2022/11/2908:01272.25 EUR0.001
Frankfurt2022/11/2818:47275.10 EUR0.024
Duesseldorf2022/11/2821:00273.65 EUR0.0012
Borsa Italiana MTF Trading After Hours2022/11/0919:08284.10 EUR0.001
Borsa Italiana MTF Global Equity Market2022/11/2817:35270.30 EUR0.001
Berlin2022/11/2908:08273.25 EUR0.001

Company Logo

Contact Details

AMGEN INC.
- -
One Amgen Center Drive - 91320-1799 Thousand Oaks
Telefon: 1-805-447-1000
Fax: 1-805-447-1010
E-mail: -

PDF Downloads

Annual report: AMGEN INC.PDF Download

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Members of Management Board

Brian DrukerMember of Board of Directors
Michael DrakeMember of Board of Directors
Omar IshrakMember of Board of Directors
Robert WilliamsMember of Board of Directors
Ronald SugarMember of Board of Directors
Tyler JacksMember of Board of Directors
Wanda AustinMember of Board of Directors
Amy MilesMember of Board of Directors
Charles HolleyMember of Board of Directors
Ellen KullmanMember of Board of Directors
Greg GarlandMember of Board of Directors
Robert EckertMember of Board of Directors
Robert BradwayChairman of Managing Board
Darryl SleepMember of Executive Committee
David ReeseMember of Executive Committee
Robert FremeauMember of Executive Committee
Arvind SoodMember of Executive Committee
David PiacquadMember of Executive Committee
Esteban SantosMember of Executive Committee
Jonathan GrahamMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.